Epitope Generation Gateway (EGG): A biological context-dependent approach to cancer vaccine development.

EGG identifies prioritized cancer vaccine epitopes from genomic variants by integrating biological context, highlighting genes essential for tumor fitness in melanoma patients.

• Why it matters: Current neoantigen discovery tools lack the ability to incorporate biological features relevant to tumor survival and immune evasion, limiting vaccine candidate effectiveness.
• What they did: EGG combines variant detection, HLA typing, and epitope prediction with network analysis, gene importance metrics, and functional annotations across 30 melanoma samples, producing ranked candidate epitopes.
• The result: This approach enables selection of epitopes from genes critical to tumor survival, supporting the development of more effective, biologically informed cancer vaccines.